An Evaluation of Probiotic in the Clinical Course of Patients With Colorectal Cancer

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 26, 2016

Primary Completion Date

November 16, 2018

Study Completion Date

November 26, 2018

Conditions
Colorectal Cancer
Interventions
DIETARY_SUPPLEMENT

Probiotic

30 billions colony-forming unit (CFU) of a mixture of six viable strains including 107 mg of Lactobacillus acidophilus BCMC® 12130, Lactobacillus lactis BCMC® 12451, Lactobacillus casei subsp BCMC® 12313, Bifidobacterium longum BCMC® 02120, Bifidobacterium bifidum BCMC® 02290 and Bifidobacterium infantis BCMC® 02129

OTHER

Placebo

Placebo samples produced were identical to the probiotics in term of taste and texture without live microorganisms.

All Listed Sponsors
lead

Dr. Liyana Zaharuddin

OTHER

NCT03782428 - An Evaluation of Probiotic in the Clinical Course of Patients With Colorectal Cancer | Biotech Hunter | Biotech Hunter